EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Is the Bearishness Around Pfizer and Gilead Sciences a Contrarian Opportunity?
Should Gilead's Revenue Beat but Softer EPS Outlook Require Action From Gilead Sciences (GILD) Investors?
Diversify Wealth Management LLC Acquires 5,072 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Bleakley Financial Group LLC Acquires 24,649 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Calamos Advisors LLC Raises Stock Holdings in Gilead Sciences, Inc. $GILD
J. Safra Sarasin Holding AG Lowers Stock Position in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. (NASDAQ:GILD) Given Average Rating of "Moderate Buy" by Analysts - Zolmax
Gilead Sciences, Inc. (NASDAQ:GILD) Receives Consensus Rating of "Moderate Buy" from Brokerages
AMF Tjanstepension AB Buys 17,302 Shares of Gilead Sciences, Inc. $GILD
Procyon Advisors LLC Increases Stock Position in Gilead Sciences, Inc. $GILD - Stock Observer
Teachers Retirement System of The State of Kentucky Has $85.62 Million Holdings in Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences (NASDAQ:GILD) Raised to Buy at Wall Street Zen
Gilead Sciences (NASDAQ:GILD) Rating Increased to Buy at Wall Street Zen
Fifth Third Bancorp Purchases 226,510 Shares of Gilead Sciences, Inc. $GILD
Wells Fargo Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)
Candriam S.C.A. Has $232.79 Million Holdings in Gilead Sciences, Inc. $GILD
Conning Inc. Decreases Position in Gilead Sciences, Inc. $GILD
Gilead Sciences Down Over 4%, on Pace for Largest Percent Decrease Since July 2025 - Data Talk | Morningstar
Ibex Wealth Advisors Has $2.14 Million Holdings in Gilead Sciences, Inc. $GILD
Gilead (GILD) Stock Looks Below Fair Value But Earnings Already Look Priced In
Sumitomo Mitsui Trust Group Inc. Trims Stock Position in Gilead Sciences, Inc. $GILD - Zolmax
Sumitomo Mitsui Trust Group Inc. Decreases Position in Gilead Sciences, Inc. $GILD - Markets Daily
Resona Asset Management Co. Ltd. Has $58.67 Million Stake in Gilead Sciences, Inc. $GILD - Stock Observer
Morgan Stanley Keeps Buy Rating on Gilead (GILD)
Pharmaceutical Stocks To Watch Now - July 8th - Markets Daily
Gilead Sciences (NASDAQ:GILD) Price Target Cut to $166.00 by Analysts at Morgan Stanley
Gilead Sciences (GILD) Could Be 53% Below Fair Value After Trodelvy Approval
O Domhnaill Enterprises Inc. Makes New Investment in Gilead Sciences, Inc. $GILD - Zolmax
15,198 Shares in Gilead Sciences, Inc. $GILD Acquired by O Domhnaill Enterprises Inc.
Gilead Sciences (NASDAQ:GILD) Given New $156.00 Price Target at Truist Financial
Swedbank AB Has $334.21 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political
Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trial
Gilead Sciences' (GILD) Overweight Rating Reaffirmed at Cantor Fitzgerald
Here Are Monday's Best Wall Street Analyst Research Calls: Agnico Eagle Mines, Datadog, Delta Air Lines, Gilead Sciences, Okta, Pfizer, Regions Financial, T-Mobile, and More
Raleigh Capital Management Inc. Sells 6,614 Shares of Gilead Sciences, Inc. $GILD
Experimental Ebola trial begins in Congo as death toll tops 500
Should First-Line Trodelvy Breast Cancer Approvals Reshape the Gilead Sciences (GILD) Investment Narrative?
Is Gilead (GILD) One of the Most Undervalued NASDAQ Stocks to Buy Right Now?
Gilead Sciences, Inc. $GILD Shares Bought by Kepler Cheuvreux Suisse SA
Berger Financial Group Inc Trims Stock Position in Gilead Sciences, Inc. $GILD
HB Wealth Management LLC Acquires 5,516 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Rep. Jared Moskowitz Purchases Gilead Sciences, Inc. (NASDAQ:GILD) Stock - Daily Political
Top Pharmaceutical Stocks To Follow Today - July 4th
QRG Capital Management Inc. Sells 15,139 Shares of Gilead Sciences, Inc. $GILD - Markets Daily
QRG Capital Management Inc. Trims Stake in Gilead Sciences, Inc. $GILD - Zolmax
Rep. Jared Moskowitz Buys Shares of Gilead Sciences, Inc. (NASDAQ:GILD) - Stock Observer
Strs Ohio Sells 30,448 Shares of Gilead Sciences, Inc. $GILD - Zolmax
Healthcare Stocks Investors Are Turning To After The Weak US Jobs Report
Y Intercept Hong Kong Ltd Buys Shares of 104,293 Gilead Sciences, Inc. $GILD
Global TROP-2 Targeted Therapy Market Set to Reach USD 3.29 Billion by 2031 with an 8.6% CAGR
Fulton Bank N.A. Sells 9,171 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Purchased by Turtle Creek Wealth Advisors LLC - Daily Political
Gilead Sciences (NASDAQ:GILD) CEO Sells 15,000 Shares of Stock
Casdatifan 在肾癌中表现出与 HIF-2α 生物学相关的持久疗效
iA Global Asset Management Inc. Trims Stake in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Purchased by USS Investment Management Ltd - Stock Observer
iA Global Asset Management Inc. Reduces Position in Gilead Sciences, Inc. $GILD - Stock Observer
Therapeutics Stocks Q1 Recap: Benchmarking Vertex Pharmaceuticals (NASDAQ:VRTX)
Forum Financial Management LP Sells 9,759 Shares of Gilead Sciences, Inc. $GILD - Zolmax
Forum Financial Management LP Decreases Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily
Janney Montgomery Scott LLC Sells 11,021 Shares of Gilead Sciences, Inc. $GILD
Patton Fund Management Inc. Has $3.01 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily
Patton Fund Management Inc. Sells 38,011 Shares of Gilead Sciences, Inc. $GILD
MFA Wealth Services Purchases Shares of 7,677 Gilead Sciences, Inc. $GILD - Markets Daily
Pictet Asset Management Holding SA Buys 218,308 Shares of Gilead Sciences, Inc. $GILD - Stock Observer
How Trodelvy's New First-Line Breast Cancer Role Could Reframe Gilead Sciences' (GILD) Investment Narrative
Medical Stocks To Follow Now - June 27th - Zolmax
Pharmaceutical Stocks To Research - June 27th - Daily Political
Sterling Capital Management LLC Has $9.27 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Stock Observer
Will Trodelvy's First-Line TNBC Approval Redefine Gilead Sciences' (GILD) Oncology-Led Investment Narrative?
Gilead Sciences (GILD) Wins First Line Trodelvy Approval In The US And Europe
VCI Wealth Management LLC Purchases Shares of 15,683 Gilead Sciences, Inc. $GILD - Daily Political
Gilead (GILD) Wins FDA Approval For Trodelvy In First Line Triple Negative Breast Cancer
Cantor Fitzgerald Reiterates Overweight Rating on Gilead Sciences (GILD) Following Positive HIV Trial Results
144,800 Shares in Gilead Sciences, Inc. $GILD Acquired by Louisiana State Employees Retirement System
Assenagon Asset Management S.A. Boosts Position in Gilead Sciences, Inc. $GILD
Gilead HSV Plan Could Transform Market Outlook
New Drugs Are Replacing Chemo for Aggressive Breast Cancer | Hindustan Times
Gilead Sciences, Inc. $GILD Shares Bought by Fifth Third Wealth Advisors LLC - Stock Observer
The case for prospective MEN1 surveillance in the era of sequential menin inhibitor therapy
5 Set-It-and-Forget-It Stocks to Buy Right Now
Miller Howard Investments Inc. NY Cuts Stock Holdings in Gilead Sciences, Inc. $GILD - Stock Observer
Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study
US provides Ebola treatment for outbreak in Congo, bringing trials closer
European Commission Grants Marketing Rights For Gilead's Trodelvy In Treating Breast Cancer
3 S&P 500 Stocks with Exciting Potential
Could This FDA Milestone Unlock Gilead's (GILD) Next Big Growth Driver?
Gilead News
IG vs Markets.com: Which is the Better Platform for CFD Trading in 2026?
Week Ahead: US June inflation and BoC rate decision are on the watch
